United StatesUnited States (Mon - Fri) 09:00-21:00 - GMT -4:00 +1-567-237-4132

Category

EV Biologics
NASHVILLE, TN / ACCESSWIRE / April 8, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director’s loan agreement to secure funding of up to $5 million to start generation of a novel exosome-producer cell line and production of therapeutic exosomes for preclinical research. The Company has finalized its preparation and...
Read More
NASHVILLE, TN / ACCESSWIRE / February 22, 2021 / EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a plan for cGMP process development and scalable biomanufacturing of exosome biopharmaceuticals. EV Biologics has designed a modular process for production of extracellular vesicles (EVs) with native...
Read More
CHEYENNE, WY / ACCESSWIRE / January 26, 2021 / EV Biologics Corp, OTC: YECO today announced that it has entered into an engagement agreement with the esteemed international law firm, Foley & Lardner LLP, est. 1842. The firm is at the top of Intellectual Property Law in Biotechnology and Organics and has a specialty in stem...
Read More
CHEYENNE, WY / ACCESSWIRE / January 4, 2021 / EV Biologics Corp (OTC:YECO) today announced that it has completed all its filings on OTC Markets with its 10K, 2020 filing today. The Company expects to become Pink Current within the next few weeks, then apply for a OTCQB listing. For the Company, being current allows the...
Read More
CHEYENNE, WY / ACCESSWIRE / November 10, 2020 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now current in its reporting showing a Yield sign. The Company targeted to become current in its reporting before the end of October and is pleased to have...
Read More
CHEYENNE, WY / ACCESSWIRE / September 29, 2020 / EV Biologics, Inc. formerly Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it intends to utilize the advanced instrumentation and research staff at the Vanderbilt Institute of Nanoscale Science and Engineering (VINSE) and the Vanderbilt Center for Structural Biology (CSB) in the development of extracellular vesicle (EV)-based...
Read More
CHEYENNE, WY / ACCESSWIRE / September 23, 2020 / Yulong Eco-Materials Limited / EV Biologics, Inc. (OTC PINK:YECO) today announced that it intends to list its Securitized Token Offering “STO” on the CryptoSX digital exchange. CryptoSX is a fully licensed and regulated Digital Assets Exchange that allows issuers to tokenize and investors to buy and sell...
Read More
CHEYENNE, WY / ACCESSWIRE / September 14, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it will focus its energies into building an incubator laboratory in Nashville,TN for the development of cell and extracellular vesicle (EV) based therapeutics. Dr. Jason Sanders recently relocated to Nashville and the Company is now negotiating lab space...
Read More
CHEYENNE, WY / ACCESSWIRE / September 9, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it intends to build an incubator laboratory for development of cell and extracellular vesicle (EV) based therapeutics. Our state-of-the-art molecular and cellular biology lab will be equipped for the development of a series of young new cells (naïve) and...
Read More
CHEYENNE, WY / ACCESSWIRE / August 31, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it has engaged Dr. Jason Sanders as Chief Medical Officer. Dr. Sanders is an expert in the science and medicine of extracellular vesicles (EVs) including exosome-based diagnostic and therapeutic technology. As an honors graduate from Harvard University, Dr. Sanders...
Read More
1 2

About the author

Hi, my name is Dennis Burns, the Investor Relations (IR) and Business Development Contact at Greenpro Capital Corp. (GRNQ). I hope you enjoyed our website and the press releases. For any inquiries, please feel free to contact me at (567)-237-4132 or at dburns@nvestrain.com